Air Pollution Tied to Cardiovascular Disease Deaths Globally
By Lori Solomon HealthDay Reporter
FRIDAY, Feb. 9, 2024 -- Air pollution is associated with higher cardiovascular disease mortality, particularly in low-income countries, according to a study published online Feb. 7 in Chronic Diseases and Translational Medicine.
Nikolai Khaltaev, M.D., from the Global Alliance against Chronic Respiratory Diseases in Geneva, and Svetlana Axelrod, M.D., Ph.D., from First Moscow State University, analyzed cardiovascular disease mortality attributed to air pollution in 183 World Health Organization member states in 2019.
The researchers found a gradual increase in cardiovascular disease mortality attributed to air pollution from high-income countries to low-income countries. In low-income countries, household air pollution is the major cause of cardiovascular disease mortality. In all countries, ischemic heart disease mortality attributed to ambient air pollution is higher than stroke mortality attributed to ambient air pollution. Mortality from stroke in low-income countries is attributed to household air pollution of 39.27, which is more than twice the stroke mortality attributed to ambient air pollution at 18.60.
"Effective air pollution control along with the lifestyle modifications and disease management should be essential components of cardiovascular disease preventive strategies," Khaltaev said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Read this next
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD
WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...
Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease
TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.